The global burden of neglected zoonotic diseases: Current state of evidence.

Burden of disease Disability-adjusted life years Neglected zoonotic diseases Years lived with disability Years of life lost

Journal

One health (Amsterdam, Netherlands)
ISSN: 2352-7714
Titre abrégé: One Health
Pays: Netherlands
ID NLM: 101660501

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 13 01 2023
revised: 22 06 2023
accepted: 25 06 2023
medline: 7 8 2023
pubmed: 7 8 2023
entrez: 7 8 2023
Statut: epublish

Résumé

The majority of emerging infectious diseases are zoonoses, most of which are classified as "neglected". By affecting both humans and animals, zoonoses pose a dual burden. The disability-adjusted life year (DALY) metric quantifies human health burden since it combines mortality and morbidity. This review aims to describe and analyze the current state of evidence on neglected zoonotic diseases (NZDs) burden and start a discussion on the current understanding of the global burden of NZDs. We identified 26 priority NZDs through consulting three international repositories for national prioritization exercises. A systematic review of global and national burden of disease (BoD) studies was conducted using pre-selected databases. Data on diseases, location and DALYs were extracted for each eligible study. A total of 1887 records were screened, resulting in 74 eligible studies. The highest number of BoD was found for non-typhoidal salmonellosis (23), whereas no estimates were found for West Nile, Marburg and Lassa fever. Geographically, the highest number of studies was performed in the Netherlands (11), China (5) and Iran (4). The number of BoD retrieved mismatched the perceived importance in national prioritization exercises. For example, anthrax was considered a priority NZD in 65 countries; however, only one national study estimating BoD was retrieved. By summing the available global estimates, the selected NZDs caused at least 21 million DALYs per year, a similar order of magnitude to (but less than) the burden due to foodborne disease (included in the Foodborne Disease Burden Epidemiology Reference Group). The global burden of disease landscape of NZDs remains scattered. There are several priority NZDs for which no burden estimates exist, and the number of BoD studies does not reflect national disease priorities. To have complete and consistent estimates of the global burden of NZDs, these diseases should be integrated in larger global burden of disease initiatives.

Identifiants

pubmed: 37545541
doi: 10.1016/j.onehlt.2023.100595
pii: S2352-7714(23)00115-5
pmc: PMC10400928
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

100595

Informations de copyright

© 2023 The Authors. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

All authors declare that they have no conflicts of interest.

Références

PLoS One. 2016 Apr 20;11(4):e0153106
pubmed: 27097024
Bull World Health Organ. 1994;72(3):429-45
pubmed: 8062401
Front Public Health. 2020 Nov 26;8:596944
pubmed: 33324602
PLoS Negl Trop Dis. 2014 Jan 02;8(1):e2634
pubmed: 24392178
PLoS Negl Trop Dis. 2021 Nov 2;15(11):e0009909
pubmed: 34727113
PLoS One. 2013 Nov 20;8(11):e79740
pubmed: 24278167
Br J Clin Pharmacol. 2022 Feb;88(2):367-373
pubmed: 34888909
PLoS Med. 2015 Dec 03;12(12):e1001920
pubmed: 26633705
Ecohealth. 2012 Jun;9(2):150-62
pubmed: 22395956
One Health. 2017 Nov 28;5:40-45
pubmed: 29911164
Nature. 2007 May 17;447(7142):279-83
pubmed: 17507975
Arch Public Health. 2020 Sep 22;78:85
pubmed: 32983448
Popul Health Metr. 2009 Jun 15;7:9
pubmed: 19527516
Int J Public Health. 2014 Jun;59(3):565-9
pubmed: 24752429
Epidemiol Infect. 2010 Nov;138(11):1650-6
pubmed: 20223049
PLoS Negl Trop Dis. 2014 Jul 24;8(7):e2865
pubmed: 25058013
Eur J Public Health. 2012 Feb;22(1):150-7
pubmed: 21183472
One Health. 2021 Jan 20;12:100216
pubmed: 33598525
Epidemiol Infect. 2000 Dec;125(3):505-22
pubmed: 11218201
Popul Health Metr. 2011 Jan 10;9(1):1
pubmed: 21219615
Epidemiol Infect. 2014 Nov;142(11):2412-21
pubmed: 24476696
J Clin Epidemiol. 2009 Oct;62(10):1006-12
pubmed: 19631508
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Euro Surveill. 2007 Dec 01;12(12):E3-4
pubmed: 18076860
PLoS Med. 2015 Dec 03;12(12):e1001921
pubmed: 26633831
World Health Organ Tech Rep Ser. 1959;58(169):1-84
pubmed: 13669510
Int J Food Microbiol. 2013 Aug 16;166(1):34-47
pubmed: 23827806
Clin Microbiol Infect. 2015 May;21(5):433-43
pubmed: 25911990
PLoS Med. 2015 Dec 03;12(12):e1001923
pubmed: 26633896

Auteurs

Carlotta Di Bari (C)

GBADs programme, University of Liverpool, United Kingdom.
Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Department of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke, Belgium.

Narmada Venkateswaran (N)

GBADs programme, University of Liverpool, United Kingdom.
Department of Health Metrics Sciences, Institute for Health Metrics and Evaluation, University of Washington, Seattle, United States.

Christina Fastl (C)

GBADs programme, University of Liverpool, United Kingdom.
Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Sarah Gabriël (S)

Department of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke, Belgium.

Delia Grace (D)

GBADs programme, University of Liverpool, United Kingdom.
Natural Resources Institute, University of Greenwich, Chatham Maritime, United Kingdom.
Animal and Human Health, International Livestock Research Institute, Nairobi, Kenya.

Arie H Havelaar (AH)

GBADs programme, University of Liverpool, United Kingdom.
Department of Animal Sciences, Emerging Pathogens Institute and Global Food Systems Institute, University of Florida, Gainesville, United States.

Ben Huntington (B)

GBADs programme, University of Liverpool, United Kingdom.
Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, UK.
Pengwern Animal Health Ltd, 259 Wallasey Village, Wallasey Wirral, Merseyside, United Kingdom.

Grace T Patterson (GT)

GBADs programme, University of Liverpool, United Kingdom.
Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.

Jonathan Rushton (J)

GBADs programme, University of Liverpool, United Kingdom.
Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, UK.

Niko Speybroeck (N)

Insititute of Health and Society (IRSS), Université Catholique de Louvain, Woluwe-Saint-Lambert, Belgium.

Paul Torgerson (P)

GBADs programme, University of Liverpool, United Kingdom.
Section of Epidemiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.

David M Pigott (DM)

GBADs programme, University of Liverpool, United Kingdom.
Department of Health Metrics Sciences, Institute for Health Metrics and Evaluation, University of Washington, Seattle, United States.

Brecht Devleesschauwer (B)

GBADs programme, University of Liverpool, United Kingdom.
Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Department of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke, Belgium.

Classifications MeSH